Open an account

Anteris Technologies Global

AVR · NASDAQ

$6.29+$0.11 (+1.78%)TodayMarket closed ·
Prev close $6.18

About AVR

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. The company is headquartered in Eagan, Minnesota and currently employs 174 full-time employees. The company went IPO on 2024-12-13. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The firm's ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.

Employees
174
Headquarters
Eagan, Minnesota
Listed
Dec 13, 2024
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
anteristech.com

AVR key statistics

Market cap
613.01M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.30M
Volume
2.83M
Open price
$6.20
High today
$6.53
Low today
$6.18
52 Week high
$11.06
52 Week low
$3.30

Anteris Technologies Global (AVR) at a glance

Anteris Technologies Global (AVR) last traded at $6.29, with a market cap of 613.01M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $6.18 and $6.53. The current price is 1.9% above the day's low and 3.6% below its high.

Volume so far is 2.83M shares, above the average of 1.30M shares a day.

Over the past year Anteris Technologies Global has ranged from $3.30 to $11.06, and now sits 39% of the way up that range.

Anteris Technologies Global met or beat analyst EPS estimates in 0 of the last 6 quarters. In Q2 FY26 it reported -$0.30 per share against an estimate of -$0.2087.

The average analyst price target is $15.05, 139.2% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

67%of 3 analyst ratings say Buy
  • Buy66.7%
  • Hold33.3%
  • Sell0.0%
Price target · 5 analystsAvg $15.05
Low
$13.13
Now
$6.29
High
$16.80

AVR earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 6 quarters.

  1. Q1 FY25: reported -$0.61 per share against an estimate of -$0.4781
  2. Q2 FY25: reported -$0.58 per share against an estimate of -$0.5387
  3. Q3 FY25: reported -$0.62 per share against an estimate of -$0.5808
  4. Q4 FY25: reported -$0.74 per share against an estimate of -$0.5959
  5. Q1 FY26: reported -$0.28 per share against an estimate of -$0.1566
  6. Q2 FY26: reported -$0.30 per share against an estimate of -$0.2087

AVR news

  • Press releaseGlobe Newswire

    Anteris Technologies Announces Results for the Second Quarter of 2026

  • Press releaseBusiness Wire

    Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

Similar companies

Companies in the same industry as Anteris Technologies Global

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.